New York State Common Retirement Fund
SGNT

New York State Common Retirement Fund’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

New York State Common Retirement Fund’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-275,921
Closed -$4.13M – 3219
2016
Q2 		$4.13M Hold
275,921
– – 0.01% 1306
2016
Q1 		$3.36M Buy
275,921
+43,650
+19% +$612K 0.01% 1379
2015
Q4 		$3.69M Buy
232,271
+50,258
+28% +$791K 0.01% 1348
2015
Q3 		$2.79M Sell
182,013
-151,526
-45% -$3.28M ﹤0.01% 1449
2015
Q2 		$8.11M Buy
333,539
+120,773
+57% +$2.89M 0.01% 1063
2015
Q1 		$4.95M Buy
212,766
+61,331
+40% +$1.62M 0.01% 1215
2014
Q4 		$3.8M Sell
151,435
-34,996
-19% -$1.03M 0.01% 1341
2014
Q3 		$5.8M Buy
186,431
+32,400
+21% +$878K 0.01% 1132
2014
Q2 		$3.98M Hold
154,031
– – 0.01% 1366
2014
Q1 		$3.6M Buy
154,031
+18,211
+13% +$398K 0.01% 1381
2013
Q4 		$3.45M Buy
+135,820
New +$3.07M 0.01% 1389

New York State Common Retirement Fund's SGNT Position: Q3 2016 in Review

New York State Common Retirement Fund sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 275,921 shares — an estimated $4.13M sold.

New York State Common Retirement Fund first reported a position in SGNT in Q4 2013 and held it in 11 quarters. The position peaked at $8.11M in Q2 2015. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • New York State Common Retirement Fund reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • New York State Common Retirement Fund sold 275,921 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $4.13M.
  • New York State Common Retirement Fund first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q4 2013 and held it in 11 quarters.
  • New York State Common Retirement Fund's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $8.11M in Q2 2015.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on New York State Common Retirement Fund's 13F filing for Q3 2016, filed 8 Nov 2016.